
Relugolix is a novel, non-peptide, orally active gonadotropin-releasing hormone (GnRH) антагонист с IC50 of 0.33 nM in the presence of 40% fetal bovine serum, TAK-385 possesses higher affinity and мощный antagonistic activity compared with TAK-013.
Relugolix is a novel, non-peptide, orally active gonadotropin-releasing hormone (GnRH) antagonist with IC50 of 0.33 nM in the presence of 40% fetal bovine serum, TAK-385 possesses higher affinity and potent antagonistic activity compared with TAK-013.
Вращайте мышью · Колесо — масштаб
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.